Bilayer Therapeutics Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
3
- Latest Deal Type
-
Out of Business
Bilayer Therapeutics General Information
Description
Operator of a biotechnology company seeks to develop bile acids as first-in-class therapies to treat several diseases of the colon. The company's technology stimulates the body's innate mechanisms for regulating constipation, enabling doctors to treat chronic idiopathic constipation, irritable bowel syndrome with constipation, and other conditions of the colon like Inflammatory bowel disease (IBD), ulcerative colitis, Crohn's disease, type 2 diabetes, obesity and metabolic disorders.
Contact Information
Website
www.bilayer-therapeutics.comCorporate Office
- One Broadway, 14th floor
- Cambridge, MA 02142
- United States
Corporate Office
- One Broadway, 14th floor
- Cambridge, MA 02142
- United States
Bilayer Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 09-Sep-2025 | Completed | Out of Business | |||
| 3. Early Stage VC (Series A) | Completed | Pre-Clinical Trials | ||||
| 2. Early Stage VC | 04-Aug-2023 | $300K | $3.9M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 13-Sep-2022 | $3.6M | $3.6M | Completed | Pre-Clinical Trials |
Bilayer Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Bilayer Therapeutics Comparisons
Industry
Financing
Details
Bilayer Therapeutics Competitors (2)
One of Bilayer Therapeutics’s 2 competitors is Ironwood Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom |
Bilayer Therapeutics Patents
Bilayer Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023192221-A1 | Forms and compositions of sodium chenodeoxycholate | Inactive | 29-Mar-2022 |
Bilayer Therapeutics Signals
Bilayer Therapeutics FAQs
-
When was Bilayer Therapeutics founded?
Bilayer Therapeutics was founded in 2020.
-
Where is Bilayer Therapeutics headquartered?
Bilayer Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Bilayer Therapeutics?
Bilayer Therapeutics has 3 total employees.
-
What industry is Bilayer Therapeutics in?
Bilayer Therapeutics’s primary industry is Drug Discovery.
-
Is Bilayer Therapeutics a private or public company?
Bilayer Therapeutics is a Private company.
-
What is Bilayer Therapeutics’s current revenue?
The current revenue for Bilayer Therapeutics is .
-
How much funding has Bilayer Therapeutics raised over time?
Bilayer Therapeutics has raised $17.9M.
-
Who are Bilayer Therapeutics’s competitors?
Ironwood Pharmaceuticals and AstraZeneca are competitors of Bilayer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process